🔴 Opus Genetics is trading 5.5% down today in a technical retrace

Opus Genetics is trading at $2.91 (5.5% down) in pre-market sessions as the stock undergoes a technical retrace following a recent recovery.

• The move follows a 5.5% rebound to $3.08 on July 24, with shares now pulling back to previous levels.
• There are no fresh company-specific headlines, earnings releases, or FDA updates tied directly to this move.
• The decline appears to be a technical correction rather than a reaction to fundamental news, especially as broader index futures remain in risk-on territory.